ALIMERA SCIENCES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 28 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-19: Reporting owner Caballa Susan; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-19: Reporting owner Caballa Susan; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-19: Reporting owner Holland David; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-19: Reporting owner Holland David; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-19 | Caballa Susan Officer (SVP,Regulatory&Medical Affairs) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | Caballa Susan Officer (SVP,Regulatory&Medical Affairs) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | Holland David Officer (SVP of Sales & Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | Holland David Officer (SVP of Sales & Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | EISWIRTH RICHARD S JR Officer (COO and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +235,000 235,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | EISWIRTH RICHARD S JR Officer (COO and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +105,000 105,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | Myers C. Daniel Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +365,000 365,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | Myers C. Daniel Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | Green Kenneth Officer (SVP & Chief Science Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +135,000 135,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-12-19 | Green Kenneth Officer (SVP & Chief Science Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $1.66 exercise price | 2012-12-21 | |
| 2012-10-02 | Kong Garheng Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $2.49 exercise price | 2012-10-04 | |
| 2012-06-14 | Brooks Mark J Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Indirect · See FN | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $2.77 exercise price | 2012-06-15 | |
| 2012-06-14 | Pizzo Peter J. III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $2.77 exercise price | 2012-06-15 | |
| 2012-06-14 | BRADLEY GLEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $2.77 exercise price | 2012-06-15 | |
| 2012-06-14 | Largent James R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $2.77 exercise price | 2012-06-15 | |
| 2012-06-14 | TRACY PHILIP R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $2.77 exercise price | 2012-06-15 | |
| 2012-06-14 | Roberts Calvin W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $2.77 exercise price | 2012-06-15 | |
| 2012-06-14 | Halak Brian K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $2.77 exercise price | 2012-06-15 | |
| 2012-02-10 | Green Kenneth Officer (SVP & Chief Scientific Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +95,000 95,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | Green Kenneth Officer (SVP & Chief Scientific Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | Holland David Officer (SVP of Sales & Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | Holland David Officer (SVP of Sales & Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | EISWIRTH RICHARD S JR Officer (COO & CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +170,000 170,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | EISWIRTH RICHARD S JR Officer (COO & CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | Caballa Susan Officer (SVP,Regulatory&Medical Affairs) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | Caballa Susan Officer (SVP,Regulatory&Medical Affairs) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | Myers C. Daniel Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $1.65 exercise price | 2012-02-14 | |
| 2012-02-10 | Myers C. Daniel Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +95,000 95,000 owned after | $1.65 exercise price | 2012-02-14 |